Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1338
| Despition | Dopamine Receptor D1 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1227 | Pax2 Blocking Peptide (AC1227) | 250 µg | inquiry |
| ACPP-1609 | Human CNTF Protein, His (AC1609) | 5 µg | inquiry |
| ACPP-1212 | PAX8 Blocking Peptide (AC1212) | 250 µg | inquiry |
| ACPP-1440 | Human SIRPA Protein (AC1440) | 5 µg | inquiry |
| ACPP-1616 | Human DGCR6 Protein (AC1616) | 5 µg | inquiry |
| ACPP-1652 | Human WWC1 Protein (AC1652) | 5 µg | inquiry |
| ACPP-1522 | Dopamine Receptor D3 Blocking Peptide (AC1522) | 250 µg | inquiry |
| ACPP-1645 | Human FAM84B Protein (AC1645) | 5 µg | inquiry |
| ACPP-1558 | Human ALK/P80 Protein (AC1558) | 2 µg | inquiry |
| ACPP-1219 | Prominin 1 Blocking Peptide (AC1219) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.